smart nanoparticles able
FR overexpressing cancer cells
intracellular compartments of cancer cells
cancer patients
smart chemotherapy
normal cells
Smart Multifunctional silica-based Nanoparticles
prototypes production
effects
Market trend
Development of new prototypes
therapy costs
drug dosage
mesoporous silica-based prototypes of nano
strategical market interests
new patent applications
customer's needs
Targeted Therapy NanoSil4Cancer project
bortezomib release
patent search
proprietary approach
technology platform
final users' needs
EU Healthcare costs
field of innovative medical technologies
folate receptor
EP06745236
Thomson
sensitive pro-drugs
folic acid
missing competence
customersâ€™ molecules
attractiveness
traditional antitumor agents
role of Big Pharma
business opportunities
feasibility study
environmental impact
vehicles
Europe
marketing
communication
SME
specific prototype
stakeholder
PCT
strong step
non-adherence
uptake of nanotechnologies
efficacy
commercial partners
therapeutic potential
sectorial report
year
device
toxicity